Cure LGS 365 Research Grants support scientists conducting basic, translational, and clinical research to close gaps in knowledge, treatment development, and care for people with Lennox-Gastaut syndrome.
Funder: Lennox-Gastaut Syndrome Foundation
Due Dates: Rolling (letters of intent) | Within 90 days of invitation (full proposals)
Funding Amounts: Grants of up to $25,000, $50,000, or $75,000 for 1–2 years
Summary: Supports basic, translational, and clinical research that advances understanding and care for people with Lennox-Gastaut syndrome.
Key Information: Full proposals are accepted by invitation only, following approval of a letter of intent.
The Lennox-Gastaut Syndrome (LGS) Foundation accepts unsolicited proposals year-round to seed innovative basic, translational, and clinical research directly relevant to LGS. Projects should address gaps in knowledge, therapeutic development, or clinical care, with a clear pathway toward impact for the LGS patient community.
Priority topics include biomarkers, mortality, sleep, medical devices, the LGS Secondary Brain Network, natural history, and neurodegeneration. The foundation also encourages work on non-seizure issues and quality of life, prevention or stabilization of LGS, and the transition from pediatric to adult care.